PMID- 23700477 OWN - NLM STAT- MEDLINE DCOM- 20131125 LR - 20220410 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 5 DP - 2013 TI - Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance. PG - e64446 LID - 10.1371/journal.pone.0064446 [doi] LID - e64446 AB - Recurrent pregnancy loss (RPL) in polycystic ovary syndrome (PCOS), which occurs in approximately 50% of total pregnancies is a frequent obstetric complication. Among the several hypotheses, insulin resistance (IR), obesity and hyperhomocysteinemia (HHcy) play significant role/s in RPL. This study was conducted to assess the link between elevated levels of homocysteine and IR in PCOS-associated women with RPL in Kolkata, India. A retrospective study was conducted of one hundred and twenty six PCOS women (<30 years) who experienced two or more spontaneous abortions during the first trimester presenting to Institute of Reproductive Medicine (IRM) in Kolkata during the period of March 2008 through February 2011. One hundred and seventeen non-PCOS subjects with matching age range were randomly chosen as controls. Incidence of HHcy and IR was 70.63% (n = 89) and 56.34% (n = 71), respectively, in RPL-affected PCOS population which was significantly higher (p<0.04; p<0.0001) when compared to the non-PCOS set (HHcy: 57.26%; IR: 6.83%). Rates of miscarriage were significantly higher (p<0.008; p<0.03) in hyperhomocysteinemia-induced miscarriage when compared to the normohomocysteinemic segment (PCOS: 70.63% vs.29.36% & non-PCOS: 57.26% vs. 42.73%) along with the insulin resistant (p<0.04; p<0.0001) population (PCOS: 70.63% vs. 56.34% & non-PCOS: 57.26% vs. 6.83%) in both groups. A probabilistic causal model evaluated HHcy as the strongest plausible factor for diagnosis of RPL. A probability percentage of 43.32% in the cases of HHcy- mediated RPL suggests its increased tendency when compared to IR mediated miscarriage (37.29%), further supported by ROC-AUC (HHcy: 0.778vs. IR: 0.601) values. Greater susceptibility towards HHcy may increase the incidence for miscarriage in women in India and highlights the need to combat the condition in RPL control programs in the subcontinent. FAU - Chakraborty, Pratip AU - Chakraborty P AD - Department of Infertility, Institute of Reproductive Medicine, Kolkata, India. FAU - Goswami, S K AU - Goswami SK FAU - Rajani, Shweta AU - Rajani S FAU - Sharma, Sunita AU - Sharma S FAU - Kabir, Syed N AU - Kabir SN FAU - Chakravarty, Baidyanath AU - Chakravarty B FAU - Jana, Kuladip AU - Jana K LA - eng PT - Journal Article DEP - 20130521 PL - United States TA - PLoS One JT - PloS one JID - 101285081 SB - IM MH - Abortion, Habitual/*etiology MH - Adult MH - Female MH - Humans MH - Hyperhomocysteinemia/complications/metabolism MH - Insulin Resistance MH - Polycystic Ovary Syndrome/*complications/*metabolism MH - Pregnancy MH - Prognosis MH - ROC Curve MH - Retrospective Studies MH - Risk Factors MH - Young Adult PMC - PMC3660299 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/05/24 06:00 MHDA- 2013/12/16 06:00 PMCR- 2013/05/21 CRDT- 2013/05/24 06:00 PHST- 2012/09/29 00:00 [received] PHST- 2013/04/15 00:00 [accepted] PHST- 2013/05/24 06:00 [entrez] PHST- 2013/05/24 06:00 [pubmed] PHST- 2013/12/16 06:00 [medline] PHST- 2013/05/21 00:00 [pmc-release] AID - PONE-D-12-29978 [pii] AID - 10.1371/journal.pone.0064446 [doi] PST - epublish SO - PLoS One. 2013 May 21;8(5):e64446. doi: 10.1371/journal.pone.0064446. Print 2013.